-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OO+7lIz/1YR/zD0lyzj6Dk4OH5Mrtb4PsWTAU32SS0rACg8E66Yt6qsFlSzGTAhf
 qRnrtuRW4ugf+Krw5Ej+yA==

<SEC-DOCUMENT>0000891836-07-000226.txt : 20070706
<SEC-HEADER>0000891836-07-000226.hdr.sgml : 20070706
<ACCEPTANCE-DATETIME>20070706144655
ACCESSION NUMBER:		0000891836-07-000226
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20070706
DATE AS OF CHANGE:		20070706

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDQUIST INC
		CENTRAL INDEX KEY:			0000884497
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		IRS NUMBER:				222531298
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-42936
		FILM NUMBER:		07967245

	BUSINESS ADDRESS:	
		STREET 1:		FIVE GREENTREE CENTRE STE 311
		STREET 2:		STATE HIGHWAY 73 N
		CITY:			MARLTON
		STATE:			NJ
		ZIP:			08053
		BUSINESS PHONE:		8568108000

	MAIL ADDRESS:	
		STREET 1:		5 GREENTREE CENTRE SUITE 311
		STREET 2:		ATTN BRUCE VAN FOSSEN
		CITY:			MARLTON
		STATE:			NJ
		ZIP:			08053

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KONINKLIJKE PHILIPS ELECTRONICS NV
		CENTRAL INDEX KEY:			0000313216
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC
		BUSINESS PHONE:		31 20 59 77777

	MAIL ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS ELECTRONICS N V
		DATE OF NAME CHANGE:	19930727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS NV
		DATE OF NAME CHANGE:	19910903
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>sc0094.txt
<DESCRIPTION>AMENDMENT NO. 4 TO SCHEDULE 13D
<TEXT>


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                 SCHEDULE 13D/A
                    Under the Securities Exchange Act of 1934

                                (Amendment No. 4)

                                  MedQuist Inc.
- --------------------------------------------------------------------------------
                                (Name of Issuer)


                           Common Stock, No Par Value
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    584949101
- --------------------------------------------------------------------------------
                                 (CUSIP Number)


                             Neil T. Anderson, Esq.
                             Sullivan & Cromwell LLP
                                125 Broad Street
                          New York, New York 10004-2498
                                 (212) 558-4000
- --------------------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                                  July 6, 2007
- --------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If a filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d- 1(g), check
the following box [ ].





<PAGE>
- --------------------------------------------------------------------------------
CUSIP NO. 584949101
- --------------------------------------------------------------------------------
 1.      NAME OF REPORTING PERSON

         Koninklijke Philips Electronics N.V.

         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

         222531298
- --------------------------------------------------------------------------------
 2.      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                                                                (a)  [_]
                                                                (b)  [_]
- --------------------------------------------------------------------------------
 3.      SEC USE ONLY

- --------------------------------------------------------------------------------
 4.      SOURCE OF FUNDS
         OO
- --------------------------------------------------------------------------------
 5.      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
         REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                     [_]
- --------------------------------------------------------------------------------
 6.      CITIZENSHIP OR PLACE OF ORGANIZATION

         The Netherlands
- --------------------------------------------------------------------------------
                  7.       SOLE VOTING POWER
  NUMBER OF                26,085,086
    SHARES        --------------------------------------------------------------
BENEFICIALLY      8.       SHARED VOTING POWER
  OWNED BY                 0
    EACH          --------------------------------------------------------------
 REPORTING        9.       SOLE DISPOSITIVE POWER
   PERSON                  26,085,086
    WITH          --------------------------------------------------------------
                  10.      SHARED DISPOSITIVE POWER
                           0
- --------------------------------------------------------------------------------
11.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
         PERSON
          26,085,086
- --------------------------------------------------------------------------------
12.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES
                                                                     [_]
- --------------------------------------------------------------------------------
13.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

         69.6%
- --------------------------------------------------------------------------------
14.      TYPE OF REPORTING PERSON
         CO

- --------------------------------------------------------------------------------

                                      -2-
<PAGE>

Item 1.  Security and Issuer.

         This Amendment No. 4 relates to the common stock, no par value (the
"Shares") of MedQuist Inc., a New Jersey corporation ("MedQuist"). This
Amendment No. 4 amends and supplements Items 4 and 5 of the Statement on
Schedule 13D dated June 6, 2000 (the "Schedule 13D") filed by Koninklijke
Philips Electronics N.V., a corporation incorporated under the laws of The
Netherlands ("Philips"), as previously amended and supplemented by Amendment No.
1 to the Schedule 13D, dated July 28, 2000, Amendment No. 2 to the Schedule 13D,
dated August 2, 2000 and Amendment No. 3 to the Schedule 13D, dated August 24,
2000. Unless otherwise defined herein, all capitalized terms used herein shall
have the meanings ascribed to them in the Schedule 13D.

Item 4.  Purpose of Transaction.

         Item 4 is hereby amended and supplemented as follows:

         On July 6, 2007, Philips publicly announced that it is reviewing all of
its options with respect to its ownership interest in MedQuist following a
determiniation by Philips that it views its MedQuist ownership interest as a
non-core holding. In connection with such review, Philips may consider possible
transactions or other changes in its MedQuist ownership interest. However, no
specific plans or proposals currently exist with respect to any of the items
enumerated in clauses (a) through (j) of Item 4 of Schedule 13D and there can be
no assurance that any transaction or other change in Philips' MedQuist ownership
interest will occur as a result of such review.

Item 5.  Interest in Securities of the Issuer.

         Item 5 is hereby amended and supplemented as follows:

         (a) As of the date hereof, Philips owns 26,085,086 Shares, which
constitutes approximately 69.6% of the outstanding Shares.

         (b) Philips has sole voting and dispositive power over 26,085,086
Shares that it owns. The agreements pursuant to which Philips disclosed in
Amendment No. 3 to the Schedule 13D that it had shared voting and/or dispositive
power over 1,841,888 Shares have expired and Philips no longer has shared voting
and/or dispositive power over such 1,841,888 Shares.



                                      -3-

<PAGE>


                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Date:  July 6, 2007



                                    KONINKLIJKE PHILIPS ELECTRONICS N.V.

                                    By:    /s/  G.J. KLEISTERLEE
                                        ----------------------------------------
                                    Name:   G.J. Kleisterlee
                                    Title:  President & CEO


                                    By:    /s/  P.J. SIVIGNON
                                        ----------------------------------------
                                    Name:   P.J. Sivignon
                                    Title:  Executive Vice President & CFO






                                      -4-

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
